| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GTPase activator activity | 8.51e-05 | 279 | 75 | 7 | GO:0005096 | |
| GeneOntologyBiologicalProcess | sebum secreting cell proliferation | 3.60e-05 | 3 | 72 | 2 | GO:1990654 | |
| GeneOntologyBiologicalProcess | TORC1 signaling | 3.97e-05 | 109 | 72 | 5 | GO:0038202 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 4.46e-05 | 20 | 72 | 3 | GO:0006607 | |
| GeneOntologyCellularComponent | super elongation complex | 1.84e-04 | 6 | 74 | 2 | GO:0032783 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 3.41e-04 | 8 | 74 | 2 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 5.46e-04 | 10 | 74 | 2 | GO:0044614 | |
| Domain | TF_AF4/FMR2 | 9.75e-05 | 4 | 76 | 2 | IPR007797 | |
| Domain | AF-4 | 9.75e-05 | 4 | 76 | 2 | PF05110 | |
| Domain | DUF3585 | 3.39e-04 | 7 | 76 | 2 | IPR022735 | |
| Domain | DUF3585 | 3.39e-04 | 7 | 76 | 2 | PF12130 | |
| Domain | Ran_BP1 | 1.05e-03 | 12 | 76 | 2 | PF00638 | |
| Domain | RANBD1 | 1.05e-03 | 12 | 76 | 2 | PS50196 | |
| Domain | - | 1.06e-03 | 391 | 76 | 7 | 2.30.29.30 | |
| Domain | RanBD | 1.24e-03 | 13 | 76 | 2 | SM00160 | |
| Domain | Ran_bind_dom | 1.24e-03 | 13 | 76 | 2 | IPR000156 | |
| Domain | PH_dom-like | 1.73e-03 | 426 | 76 | 7 | IPR011993 | |
| Domain | RhoGAP | 2.06e-03 | 62 | 76 | 3 | SM00324 | |
| Domain | RhoGAP | 2.16e-03 | 63 | 76 | 3 | PF00620 | |
| Domain | UBA-like | 2.26e-03 | 64 | 76 | 3 | IPR009060 | |
| Domain | RHOGAP | 2.26e-03 | 64 | 76 | 3 | PS50238 | |
| Domain | RhoGAP_dom | 2.26e-03 | 64 | 76 | 3 | IPR000198 | |
| Domain | - | 2.26e-03 | 64 | 76 | 3 | 1.10.555.10 | |
| Domain | Zinc_finger_PHD-type_CS | 2.36e-03 | 65 | 76 | 3 | IPR019786 | |
| Domain | CH | 2.36e-03 | 65 | 76 | 3 | SM00033 | |
| Domain | CH | 2.91e-03 | 70 | 76 | 3 | PF00307 | |
| Domain | - | 3.03e-03 | 71 | 76 | 3 | 1.10.418.10 | |
| Domain | CH | 3.28e-03 | 73 | 76 | 3 | PS50021 | |
| Domain | CH-domain | 3.54e-03 | 75 | 76 | 3 | IPR001715 | |
| Domain | Znf_C2H2_jaz | 3.58e-03 | 22 | 76 | 2 | IPR022755 | |
| Domain | zf-C2H2_jaz | 3.58e-03 | 22 | 76 | 2 | PF12171 | |
| Domain | Znf_PHD-finger | 4.10e-03 | 79 | 76 | 3 | IPR019787 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MICALL1 PCNX2 MYCL RANBP10 SZT2 FURIN GTSE1 NFX1 COBL MICAL3 ZC3H7B MBD5 CIC HIRA | 1.52e-07 | 1105 | 78 | 14 | 35748872 |
| Pubmed | 1.26e-06 | 242 | 78 | 7 | 34011540 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | MICALL1 CEP350 RANBP2 CENPE GTSE1 NFX1 TNRC6B COBL MICAL3 TMEM131 YES1 | 3.16e-06 | 853 | 78 | 11 | 28718761 |
| Pubmed | 4.84e-06 | 15 | 78 | 3 | 14697343 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 28514967 | ||
| Pubmed | USP32 is an active, membrane-bound ubiquitin protease overexpressed in breast cancers. | 4.97e-06 | 2 | 78 | 2 | 20549504 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 9325052 | ||
| Pubmed | DYRK3 dual-specificity kinase attenuates erythropoiesis during anemia. | 4.97e-06 | 2 | 78 | 2 | 18854306 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 39178863 | ||
| Pubmed | Regulation of Stress Responses and Translational Control by Coronavirus. | 4.97e-06 | 2 | 78 | 2 | 27384577 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 22983539 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 39031635 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 38519031 | ||
| Pubmed | TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells. | 4.97e-06 | 2 | 78 | 2 | 32703818 | |
| Pubmed | Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity. | 4.97e-06 | 2 | 78 | 2 | 35343766 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | MICALL1 CEP350 RANBP2 ATXN2 KDM5A SQSTM1 NFX1 TNRC6B TMEM131 HIRA | 5.05e-06 | 724 | 78 | 10 | 36232890 |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 7.64e-06 | 208 | 78 | 6 | 33230847 | |
| Pubmed | 8.97e-06 | 608 | 78 | 9 | 16713569 | ||
| Pubmed | ACE2, TMPRSS2, and Furin variants and SARS-CoV-2 infection in Madrid, Spain. | 1.49e-05 | 3 | 78 | 2 | 32691890 | |
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 33243086 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 34726347 | ||
| Pubmed | TMPRSS2 promotes SARS-CoV-2 evasion from NCOA7-mediated restriction. | 1.49e-05 | 3 | 78 | 2 | 34807954 | |
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 21149568 | ||
| Pubmed | IQCJ-SCHIP1, a novel fusion transcript encoding a calmodulin-binding IQ motif protein. | 1.49e-05 | 3 | 78 | 2 | 17045569 | |
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 34356057 | ||
| Pubmed | Tobacco Smoking Increases the Lung Gene Expression of ACE2, the Receptor of SARS-CoV-2. | 1.49e-05 | 3 | 78 | 2 | 32329629 | |
| Pubmed | Erythropoietin-dependent erythropoiesis: New insights and questions. | 1.49e-05 | 3 | 78 | 2 | 16524748 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 2.01e-05 | 146 | 78 | 5 | 23892456 | |
| Pubmed | Gene-trap mutagenesis using Mol/MSM-1 embryonic stem cells from MSM/Ms mice. | 2.39e-05 | 74 | 78 | 4 | 23604909 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PCNX2 CACNA1C ATXN2 MYT1 AFF3 TNRC6B TMPRSS2 COBL AFF1 MICAL3 QSER1 MBD5 INKA2 | 2.54e-05 | 1489 | 78 | 13 | 28611215 |
| Pubmed | 2.88e-05 | 263 | 78 | 6 | 34702444 | ||
| Pubmed | 2.97e-05 | 4 | 78 | 2 | 35038715 | ||
| Pubmed | 2.97e-05 | 4 | 78 | 2 | 23027925 | ||
| Pubmed | COVID-19 and Genetic Variants of Protein Involved in the SARS-CoV-2 Entry into the Host Cells. | 2.97e-05 | 4 | 78 | 2 | 32867305 | |
| Pubmed | 2.97e-05 | 4 | 78 | 2 | 27979964 | ||
| Pubmed | Impaired conditioned fear and enhanced long-term potentiation in Fmr2 knock-out mice. | 2.97e-05 | 4 | 78 | 2 | 11923441 | |
| Pubmed | PRDI-BF1/Blimp-1 repression is mediated by corepressors of the Groucho family of proteins. | 2.97e-05 | 4 | 78 | 2 | 9887105 | |
| Pubmed | 2.97e-05 | 4 | 78 | 2 | 17442045 | ||
| Pubmed | 2.97e-05 | 4 | 78 | 2 | 30158642 | ||
| Pubmed | 4.94e-05 | 5 | 78 | 2 | 25950943 | ||
| Pubmed | 4.94e-05 | 5 | 78 | 2 | 12604796 | ||
| Pubmed | 4.94e-05 | 5 | 78 | 2 | 25015291 | ||
| Pubmed | 4.94e-05 | 5 | 78 | 2 | 16104380 | ||
| Pubmed | 4.94e-05 | 5 | 78 | 2 | 12110185 | ||
| Pubmed | 4.94e-05 | 5 | 78 | 2 | 18550753 | ||
| Pubmed | 4.94e-05 | 5 | 78 | 2 | 28504705 | ||
| Pubmed | Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα. | 5.76e-05 | 182 | 78 | 5 | 32239614 | |
| Pubmed | RGPD4 RANBP10 RANBP2 ARHGAP24 CENPE ATXN2 KDM5A TNRC6B QSER1 HIRA | 5.80e-05 | 963 | 78 | 10 | 28671696 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 5.92e-05 | 774 | 78 | 9 | 15302935 | |
| Pubmed | Multiomics approach reveals the ubiquitination-specific processes hijacked by SARS-CoV-2. | 7.40e-05 | 6 | 78 | 2 | 36071039 | |
| Pubmed | TAF3 ATXN2 KDM5A SQSTM1 UBXN7 NFYC GATA6 TNRC6B QSER1 CIC HIRA PRDM1 | 7.81e-05 | 1429 | 78 | 12 | 35140242 | |
| Pubmed | 1.04e-04 | 7 | 78 | 2 | 8921405 | ||
| Pubmed | 1.04e-04 | 7 | 78 | 2 | 21205196 | ||
| Pubmed | 1.04e-04 | 7 | 78 | 2 | 18949001 | ||
| Pubmed | 1.04e-04 | 7 | 78 | 2 | 25187515 | ||
| Pubmed | 1.04e-04 | 7 | 78 | 2 | 9037092 | ||
| Pubmed | 1.04e-04 | 7 | 78 | 2 | 8603673 | ||
| Pubmed | 1.04e-04 | 7 | 78 | 2 | 26632511 | ||
| Pubmed | 1.04e-04 | 7 | 78 | 2 | 24403063 | ||
| Pubmed | 1.04e-04 | 7 | 78 | 2 | 23818861 | ||
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 1.04e-04 | 7 | 78 | 2 | 11353387 | |
| Pubmed | 1.04e-04 | 7 | 78 | 2 | 30944974 | ||
| Pubmed | 1.04e-04 | 7 | 78 | 2 | 38838144 | ||
| Pubmed | 1.04e-04 | 7 | 78 | 2 | 23536549 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 1.04e-04 | 7 | 78 | 2 | 7559465 | |
| Pubmed | 1.04e-04 | 7 | 78 | 2 | 12562828 | ||
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 1.04e-04 | 7 | 78 | 2 | 17372272 | |
| Pubmed | 1.04e-04 | 7 | 78 | 2 | 38657106 | ||
| Pubmed | 1.04e-04 | 7 | 78 | 2 | 12191015 | ||
| Pubmed | 1.04e-04 | 7 | 78 | 2 | 22821000 | ||
| Pubmed | 1.04e-04 | 7 | 78 | 2 | 20682751 | ||
| Pubmed | 1.05e-04 | 481 | 78 | 7 | 28190767 | ||
| Pubmed | 1.10e-04 | 209 | 78 | 5 | 36779422 | ||
| Pubmed | RANBP2 ATXN2 KDM5A SQSTM1 NFX1 TNRC6B ZC3H7B YES1 SPECC1 SPTY2D1 CIC HIRA | 1.21e-04 | 1497 | 78 | 12 | 31527615 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 1.38e-04 | 8 | 78 | 2 | 22262462 | |
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 1.38e-04 | 8 | 78 | 2 | 21670213 | |
| Pubmed | Imaging within single NPCs reveals NXF1's role in mRNA export on the cytoplasmic side of the pore. | 1.38e-04 | 8 | 78 | 2 | 31375530 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 1.38e-04 | 8 | 78 | 2 | 28745977 | |
| Pubmed | 1.38e-04 | 8 | 78 | 2 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 1.38e-04 | 8 | 78 | 2 | 21310149 | |
| Pubmed | 1.39e-04 | 116 | 78 | 4 | 30652415 | ||
| Pubmed | 1.46e-04 | 222 | 78 | 5 | 37071664 | ||
| Pubmed | GGAPs, a new family of bifunctional GTP-binding and GTPase-activating proteins. | 1.77e-04 | 9 | 78 | 2 | 12640130 | |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 1.77e-04 | 9 | 78 | 2 | 18394993 | |
| Pubmed | 1.77e-04 | 9 | 78 | 2 | 11553612 | ||
| Pubmed | 1.77e-04 | 9 | 78 | 2 | 10601307 | ||
| Pubmed | 1.77e-04 | 9 | 78 | 2 | 9733766 | ||
| Pubmed | 1.77e-04 | 9 | 78 | 2 | 28100513 | ||
| Pubmed | 1.77e-04 | 9 | 78 | 2 | 28877029 | ||
| Pubmed | 1.77e-04 | 9 | 78 | 2 | 17887960 | ||
| Pubmed | 1.88e-04 | 529 | 78 | 7 | 14621295 | ||
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | 2.04e-04 | 536 | 78 | 7 | 15840001 | |
| Pubmed | 2.09e-04 | 538 | 78 | 7 | 10512203 | ||
| Pubmed | AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release. | 2.21e-04 | 10 | 78 | 2 | 20664521 | |
| Pubmed | 2.21e-04 | 10 | 78 | 2 | 20123909 | ||
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 2.21e-04 | 10 | 78 | 2 | 8857542 | |
| Pubmed | 2.21e-04 | 10 | 78 | 2 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 2.21e-04 | 10 | 78 | 2 | 16332688 | |
| Pubmed | 2.21e-04 | 10 | 78 | 2 | 21859863 | ||
| Pubmed | AGAP1, a novel binding partner of nitric oxide-sensitive guanylyl cyclase. | 2.70e-04 | 11 | 78 | 2 | 15381706 | |
| Cytoband | 2q12.3 | 3.81e-04 | 17 | 78 | 2 | 2q12.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q13 | 2.46e-03 | 330 | 78 | 4 | chr22q13 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 4.30e-05 | 4 | 49 | 2 | 1145 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 2.56e-04 | 9 | 49 | 2 | 1280 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 3.35e-04 | 50 | 49 | 3 | 721 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 9.53e-04 | 17 | 49 | 2 | 1291 | |
| GeneFamily | PHD finger proteins | 1.86e-03 | 90 | 49 | 3 | 88 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 2.07e-03 | 25 | 49 | 2 | 775 | |
| GeneFamily | WD repeat domain containing|Caspase recruitment domain containing|Apoptosome | 2.98e-03 | 30 | 49 | 2 | 959 | |
| GeneFamily | ArfGAPs | 3.60e-03 | 33 | 49 | 2 | 395 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 3.73e-03 | 115 | 49 | 3 | 769 | |
| GeneFamily | Ubiquitin specific peptidases | 1.01e-02 | 56 | 49 | 2 | 366 | |
| GeneFamily | LIM domain containing | 1.12e-02 | 59 | 49 | 2 | 1218 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | CEP350 USP6 SCHIP1 CENPE ATXN2 KDM5A NFYC AFF1 MICAL3 TMEM131 HIRA | 1.16e-07 | 466 | 77 | 11 | M13522 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CEP350 USP6 RANBP2 SCHIP1 CENPE ATXN2 KDM5A UBXN7 NFYC AFF1 MICAL3 TMEM131 HIRA | 1.17e-06 | 856 | 77 | 13 | M4500 |
| Coexpression | FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS | 3.71e-06 | 311 | 77 | 8 | M61 | |
| Coexpression | GSE4748_LPS_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP | 2.33e-05 | 194 | 77 | 6 | M6493 | |
| Coexpression | GSE40273_XBP1_KO_VS_WT_TREG_DN | 2.69e-05 | 199 | 77 | 6 | M9124 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.13e-05 | 167 | 78 | 5 | c4e321bb87512ea839f324c92c0f1afea891483f | |
| ToppCell | Control-B_cells-Activated_B_cells|Control / group, cell type (main and fine annotations) | 1.16e-05 | 168 | 78 | 5 | a7159a35fe37f8c241cf8d391debe271e0698105 | |
| ToppCell | Control-Lymphoid-pDC|Control / Condition, Lineage and Cell class | 1.45e-05 | 176 | 78 | 5 | 5de16ff65476bde8b23322a44e11412e14f1bafe | |
| ToppCell | COVID-19-B_cells-Activated_B_cells|COVID-19 / group, cell type (main and fine annotations) | 1.49e-05 | 177 | 78 | 5 | 653bb62a3744d4024ab3186ee01d410ed62832a6 | |
| ToppCell | IPF-Lymphoid-B|World / Disease state, Lineage and Cell class | 1.62e-05 | 180 | 78 | 5 | 30f9398c9b784f49470847a025bac90687e997a1 | |
| ToppCell | Control-Lymphoid-B|World / Disease state, Lineage and Cell class | 1.66e-05 | 181 | 78 | 5 | 9124f1a610cfc3355ad87921cd3eb5346956475d | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B-B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.66e-05 | 181 | 78 | 5 | 8d8cc4dae2c8bd5f4b1c159f2a52edc4c9449c86 | |
| ToppCell | IPF-Lymphoid-B|IPF / Disease state, Lineage and Cell class | 1.75e-05 | 183 | 78 | 5 | e37d2c015c34471a8a54a0299e94b0371e1ada5a | |
| ToppCell | nucseq-Immune-Lymphocytic_B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.80e-05 | 184 | 78 | 5 | 911658e7bb499c1bbc8419eec8ff88729bc39a75 | |
| ToppCell | Control-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 1.80e-05 | 184 | 78 | 5 | c6affa0b12510363258f65e46bf2d47bf4a8e75f | |
| ToppCell | Control-Lymphoid-B|Control / Disease state, Lineage and Cell class | 1.80e-05 | 184 | 78 | 5 | de0294f879268bfd68e91adcc2adba211d221b7a | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.80e-05 | 184 | 78 | 5 | 942b58ae7172bb5f97e55b032db9329d161854af | |
| ToppCell | Fetal_29-31_weeks-Immune-enucleated_erythrocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.84e-05 | 185 | 78 | 5 | e8f7da9641b6cf1db1093b4f301ce828fd3a529c | |
| ToppCell | COPD-Lymphoid-B|COPD / Disease state, Lineage and Cell class | 1.84e-05 | 185 | 78 | 5 | 925e79c35c381dd44ec5fb921dca09ce43140135 | |
| ToppCell | COPD-Lymphoid-B|World / Disease state, Lineage and Cell class | 1.84e-05 | 185 | 78 | 5 | 22891ed75e25ef30dfa541cb82d85e08ce07e7d9 | |
| ToppCell | Immune-enucleated_erythrocyte|World / Lineage, Cell type, age group and donor | 1.89e-05 | 186 | 78 | 5 | f9d5ec5cc8fd6e63bf25abe390307ec8a4a2d5a3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-05 | 186 | 78 | 5 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | Control-Myeloid-cDC1|Control / Disease state, Lineage and Cell class | 1.89e-05 | 186 | 78 | 5 | b05c394aa3573ba855abc3066739ca193883b0c3 | |
| ToppCell | Fetal_29-31_weeks-Immune-enucleated_erythrocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.04e-05 | 189 | 78 | 5 | 1900e574870fc647bfa11c732a72f3d38aab717c | |
| ToppCell | COPD-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 2.15e-05 | 191 | 78 | 5 | 3480e6d27dd4291765bbbb2acdb6a2e4f02c8085 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.20e-05 | 192 | 78 | 5 | 25378b5e4b0cea8415ff125783511fc25a56fc00 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.26e-05 | 193 | 78 | 5 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.32e-05 | 194 | 78 | 5 | 5cd72330c9d9bb21b6c9d5d35085eade101486d1 | |
| ToppCell | Control-Multiplet|Control / Disease state, Lineage and Cell class | 2.37e-05 | 195 | 78 | 5 | 618900c80bea09d46dad3f741bd1bff8bf0a64ee | |
| ToppCell | Control-Multiplet-Multiplet|Control / Disease state, Lineage and Cell class | 2.37e-05 | 195 | 78 | 5 | 06ac685855e14e4dd2cbe6d0e73f894f2eeff91f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-05 | 196 | 78 | 5 | 2b36b9a40fe415917afccff99ad9c3474e087d0d | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.49e-05 | 197 | 78 | 5 | f0475ad9c09c6da418dba17d3d3c1aaa2ef9ab4e | |
| ToppCell | severe-pDC|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.55e-05 | 198 | 78 | 5 | 22da4a29b9ff8b94d98bc69b4632a2a58d5dd9e6 | |
| ToppCell | severe-pDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.55e-05 | 198 | 78 | 5 | 3c4820a8391088682fb3e47b914f872533bae227 | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.68e-05 | 200 | 78 | 5 | f100edfd2b3b742458cbbf34de9c403c4d272d3c | |
| ToppCell | TCGA-Bladder|World / Sample_Type by Project: Shred V9 | 1.13e-04 | 142 | 78 | 4 | 58d1fdc5ec4e5bf307b7a502c081a8a84d7560cd | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.16e-04 | 143 | 78 | 4 | 9836a040a2ebcf6f05431e658a7b8fd566621452 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.16e-04 | 143 | 78 | 4 | 4622c221b5d2d4cd4f37e4f81662e073924e1507 | |
| ToppCell | Bronchus_Control_(B.)-Immune-TX-TRAM-3|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.29e-04 | 147 | 78 | 4 | 50a855aa7f214c3be8ac46a22adf9bc9dd0285db | |
| ToppCell | Enthrocyte|World / shred on cell class and cell subclass (v4) | 1.51e-04 | 153 | 78 | 4 | 654265f3c14344071b2af7ca05cbdbb17ce2c5d3 | |
| ToppCell | Enthrocyte|World / shred on cell class and cell subclass (v4) | 1.51e-04 | 153 | 78 | 4 | 105b91f5277d145f7717307d7eb9b7d8e8e23576 | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-CD4_CTL|Leuk-UTI / Disease, Lineage and Cell Type | 1.55e-04 | 154 | 78 | 4 | 170a421fd69dba2929568c72e983ae9cfaf2aabc | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Lypd1_Gpr88|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.67e-04 | 157 | 78 | 4 | 5aee90ad7aaa65fdabc23597451da5e48db8f4e6 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.71e-04 | 158 | 78 | 4 | 216b3f482daa2d0d7fcaf5a8559e3ccbdb8e110d | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.71e-04 | 158 | 78 | 4 | 9712bb8b1bacb8a38c99a22bc2babec5d5160e2a | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Pld5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.75e-04 | 159 | 78 | 4 | a082e770fa757c4a1d3ed13d53f83297e36faf05 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Cbln4_Fezf2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.79e-04 | 160 | 78 | 4 | d8241404d775f9a709abdf17988f36293fcf4c58 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.79e-04 | 160 | 78 | 4 | d783d29150033e9181c0e30870070268fed3fd85 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-04 | 162 | 78 | 4 | 5f009b231f21861afee9cc0c569082e1135f929c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-04 | 162 | 78 | 4 | b936f8040dcd4db621ccded19237af8df7d0ed6e | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Serous_adenocarcinoma|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.97e-04 | 164 | 78 | 4 | 08c725548e751f815b4df778607270498204b353 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.97e-04 | 164 | 78 | 4 | e3983f655cdba308fb192182829f17bef99ce0ba | |
| ToppCell | facs-Spleen-nan-18m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-04 | 166 | 78 | 4 | 8d535fab019356894b4dad3fbdbc4d2ad3e16082 | |
| ToppCell | facs-Spleen-nan-18m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-04 | 166 | 78 | 4 | f56b1c0d6cb5353a16a2598bda905287f16d2c39 | |
| ToppCell | facs-Spleen-nan-18m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-04 | 166 | 78 | 4 | a5074c96c6561273029aceb93402a7e038140f50 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.11e-04 | 167 | 78 | 4 | f1ce6e64ebede1f3ef36fe982f46919fd1f814dd | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-04 | 168 | 78 | 4 | 17fb9426eeea407b26fb895b8397faca95b7552d | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-04 | 168 | 78 | 4 | a61b39884851384cffd430079040546d125b2b40 | |
| ToppCell | mild_COVID-19-HSPC|mild_COVID-19 / disease group, cell group and cell class (v2) | 2.16e-04 | 168 | 78 | 4 | 90b33962adb77d8326dee403712118398b4d1315 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_E|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.21e-04 | 169 | 78 | 4 | 0d96c0b4fd26fbc0bf44ff7bed2936eebcc55b74 | |
| ToppCell | 343B-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.21e-04 | 169 | 78 | 4 | 632aa3ab39ec87bafcefec6cddf71129a054d3b0 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-04 | 170 | 78 | 4 | a965e3ee6818790a4a6916824fde64333d9b11b7 | |
| ToppCell | mild_COVID-19-HSPC|World / disease group, cell group and cell class (v2) | 2.26e-04 | 170 | 78 | 4 | 85c476e0bc496445e868a88849960598d97bdea2 | |
| ToppCell | Children_(3_yrs)-Immune-B_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.26e-04 | 170 | 78 | 4 | e421f9eedf74baffda1d03707a710ece4b777f29 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Penk_Col27a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.31e-04 | 171 | 78 | 4 | d07e2c5f7d7f12c68860d4161d76372de174f1d8 | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.31e-04 | 171 | 78 | 4 | 6a5ac0f56bd7b4543be103100fb735ca6bc5b8bf | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.36e-04 | 172 | 78 | 4 | 858cee96c1c06160863b4adcd7023c0d678bd50f | |
| ToppCell | 10x5'-Lung-Lymphocytic_B-Memory_B_cells|Lung / Manually curated celltypes from each tissue | 2.36e-04 | 172 | 78 | 4 | 2cb2dc7cfd6db5a98a393b1a84c23abf3d692a53 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-04 | 173 | 78 | 4 | 1b9b4e165121b08ef15a93fca6bea875cae69f19 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-04 | 173 | 78 | 4 | c25f24d7b672c9686d31ebc8d263042282f520fd | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors|lymph-node_spleen / Manually curated celltypes from each tissue | 2.47e-04 | 174 | 78 | 4 | 029394e107bf7ad58056d2216070aa2e964fff12 | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-04 | 175 | 78 | 4 | d2ff8fedca9039cbd45cfd9dec88f4edbe7fe4fc | |
| ToppCell | 343B-Myeloid-Dendritic-pDC|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 2.52e-04 | 175 | 78 | 4 | b30589ff9dc18e745afe61f289e6d576c9c6c6b2 | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-04 | 175 | 78 | 4 | a7310950e8d51b3004ea3aee8ce9948fe8655112 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.52e-04 | 175 | 78 | 4 | c227fc5d1ccb69b82a96a6354913cafaf27d0eec | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.52e-04 | 175 | 78 | 4 | 73f25bd54309aed1480ddc44bdab518b17e71f92 | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-04 | 176 | 78 | 4 | fc51e4dcad5456c229d76fdcb9a80c4c79eacf3f | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors-HSC-MPP|lymph-node_spleen / Manually curated celltypes from each tissue | 2.58e-04 | 176 | 78 | 4 | de67ed15a50d2515ba6d152c1011a3367f77aedd | |
| ToppCell | Control-B_cells-B_cells|Control / group, cell type (main and fine annotations) | 2.58e-04 | 176 | 78 | 4 | d2c353783bd78dc24f28e00d917b88d8294fb5df | |
| ToppCell | COVID-19-lung-B_cells|lung / Disease (COVID-19 only), tissue and cell type | 2.63e-04 | 177 | 78 | 4 | f54691e5558091c1734ab15153a10bff15ed171e | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-04 | 177 | 78 | 4 | 8a0f0fbb06cdacb99a3fdba0da3e0494b891db4f | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.63e-04 | 177 | 78 | 4 | b59967219f7d874805768e247c0eb2bc4d4420c8 | |
| ToppCell | COPD-Epithelial-Aberrant_Basaloid|World / Disease state, Lineage and Cell class | 2.63e-04 | 177 | 78 | 4 | 22b7cda748cf5e665be54ca5bae89f0c130d5e7f | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-04 | 177 | 78 | 4 | e9d7682517fb30fd2ad535d59779d718a7024c13 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.63e-04 | 177 | 78 | 4 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-04 | 178 | 78 | 4 | dfed0fbf7a73b8a9e00178ec58dc4592b271c344 | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.69e-04 | 178 | 78 | 4 | 8bae5db100f4563aa1fc7f881e7f8c59d669e37a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-04 | 178 | 78 | 4 | d4ecb84e9b1f4ec49c519321156aa10f9bd34cce | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.69e-04 | 178 | 78 | 4 | bc0336692b84bd0fa49747ed5a031b8ed8afa0fd | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-04 | 178 | 78 | 4 | a0ab20c588e7d43d0320d4779d9ab95c1c86e297 | |
| ToppCell | droplet-Spleen-nan-24m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-04 | 179 | 78 | 4 | f3f9c7e575bc4d9d3bce649b90254182e8f6aaec | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.75e-04 | 179 | 78 | 4 | d0fa700648db8ce76a8aa689879a25048299fa40 | |
| ToppCell | droplet-Spleen-nan-24m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-04 | 179 | 78 | 4 | 01e0b49e7f03ac9c3e6c34708ead300d27236b8b | |
| ToppCell | Children_(3_yrs)-Immune-B_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.75e-04 | 179 | 78 | 4 | 31411780f1a44bf2d102f288416e97eacec4b6b6 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.75e-04 | 179 | 78 | 4 | 2e49b215b71438400aebb483f2c2c08d5e956961 | |
| ToppCell | Children_(3_yrs)-Immune-B_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.81e-04 | 180 | 78 | 4 | 40a12eb852373ae3d7c8d9bca376b0ae99f724b3 | |
| ToppCell | 18-Airway-RBC|Airway / Age, Tissue, Lineage and Cell class | 2.81e-04 | 180 | 78 | 4 | 35bf5f35cf346a5b27f5e819b77db34130d70db1 | |
| ToppCell | 18-Airway-RBC-RBC|Airway / Age, Tissue, Lineage and Cell class | 2.81e-04 | 180 | 78 | 4 | 3b4b220a3c150426ae55239baff756f1a7f1e1d7 | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.87e-04 | 181 | 78 | 4 | dff264815a3569f5666d0bbc3867c0496cd78774 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.87e-04 | 181 | 78 | 4 | bd7e9437839bca543ca5945df43d6525e6a312a8 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.87e-04 | 181 | 78 | 4 | 58f76bb9ea1518c2b629a0256a3f6595a9278152 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-secretory_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-04 | 181 | 78 | 4 | b203b616584cdbd0bbb0e382b2916d0bd49d3526 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Reg4/cKit+_deep_crypt_secretory_cells_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-04 | 181 | 78 | 4 | c748c16fd20d1949d33ff6290dc9d9016c4dc86c | |
| ToppCell | RA-07._Pericyte|World / Chamber and Cluster_Paper | 2.93e-04 | 182 | 78 | 4 | 2075efeae633550fb2eb026d0dfd741c8252482e | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.93e-04 | 182 | 78 | 4 | e67f3234165199085c793915ebb1f9bbd845e933 | |
| Drug | 2-propylpentanoic acid; Down 200; 500uM; MCF7; HT_HG-U133A | 4.80e-06 | 195 | 78 | 7 | 1665_DN | |
| Drug | Dorzolamide hydrochloride [130693-82-2]; Down 200; 11uM; PC3; HT_HG-U133A | 5.13e-06 | 197 | 78 | 7 | 5785_DN | |
| Drug | Bumetanide [28395-03-1]; Down 200; 11uM; MCF7; HT_HG-U133A | 5.13e-06 | 197 | 78 | 7 | 7440_DN | |
| Drug | Cisapride [81098-60-4]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 5.30e-06 | 198 | 78 | 7 | 3305_DN | |
| Disease | Antihypertensive use measurement | 5.61e-06 | 265 | 76 | 7 | EFO_0009927 | |
| Disease | cortical thickness | MICALL1 ZNF438 ATXN2 FURIN LAMA1 TNRC6B AFF1 MICAL3 TMEM131 IQCJ-SCHIP1 QSER1 SPECC1 | 2.61e-05 | 1113 | 76 | 12 | EFO_0004840 |
| Disease | hypothyroidism | 9.37e-05 | 284 | 76 | 6 | EFO_0004705 | |
| Disease | cryptic phenotype measurement | 2.45e-04 | 47 | 76 | 3 | EFO_0021487 | |
| Disease | diastolic blood pressure, alcohol drinking | 2.50e-04 | 118 | 76 | 4 | EFO_0004329, EFO_0006336 | |
| Disease | cerebral palsy (implicated_via_orthology) | 2.91e-04 | 10 | 76 | 2 | DOID:1969 (implicated_via_orthology) | |
| Disease | systolic blood pressure, alcohol drinking | 3.40e-04 | 128 | 76 | 4 | EFO_0004329, EFO_0006335 | |
| Disease | diastolic blood pressure, alcohol consumption measurement | 3.71e-04 | 54 | 76 | 3 | EFO_0006336, EFO_0007878 | |
| Disease | neuroimaging measurement | ZNF438 STAC2 SZT2 ATXN2 FURIN AFF3 TNRC6B AFF1 IQCJ-SCHIP1 QSER1 | 4.08e-04 | 1069 | 76 | 10 | EFO_0004346 |
| Disease | tumor necrosis factor measurement | 6.73e-04 | 15 | 76 | 2 | EFO_0010834 | |
| Disease | pulse pressure measurement | ARHGAP42 ZNF438 ARHGAP24 KDM5A MYT1 FURIN TNRC6B FHOD3 IQCJ-SCHIP1 MBD5 YES1 | 8.46e-04 | 1392 | 76 | 11 | EFO_0005763 |
| Disease | diet measurement, HOMA-B | 1.09e-03 | 19 | 76 | 2 | EFO_0004469, EFO_0008111 | |
| Disease | hypertension | 1.19e-03 | 307 | 76 | 5 | EFO_0000537 | |
| Disease | Attention Deficit Disorder | 1.46e-03 | 22 | 76 | 2 | C0041671 | |
| Disease | Minimal Brain Dysfunction | 1.46e-03 | 22 | 76 | 2 | C1321905 | |
| Disease | cholelithiasis | 1.54e-03 | 88 | 76 | 3 | EFO_0004799 | |
| Disease | diastolic blood pressure, systolic blood pressure | 1.70e-03 | 670 | 76 | 7 | EFO_0006335, EFO_0006336 | |
| Disease | parental longevity | 1.74e-03 | 494 | 76 | 6 | EFO_0007796 | |
| Disease | Attention deficit hyperactivity disorder | 1.74e-03 | 24 | 76 | 2 | C1263846 | |
| Disease | mean arterial pressure | 1.83e-03 | 499 | 76 | 6 | EFO_0006340 | |
| Disease | mean arterial pressure, alcohol drinking | 2.10e-03 | 98 | 76 | 3 | EFO_0004329, EFO_0006340 | |
| Disease | glaucoma (biomarker_via_orthology) | 2.37e-03 | 28 | 76 | 2 | DOID:1686 (biomarker_via_orthology) | |
| Disease | Thyroid preparation use measurement | 2.41e-03 | 217 | 76 | 4 | EFO_0009933 | |
| Disease | Amyotrophic Lateral Sclerosis With Dementia | 2.54e-03 | 29 | 76 | 2 | C0393554 | |
| Disease | longevity, healthspan, parental longevity | 2.54e-03 | 29 | 76 | 2 | EFO_0004300, EFO_0007796, EFO_0009762 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KVEKSPTTATGNSSC | 176 | Q9H6B1 | |
| PNCRTSVPSSKGSSS | 401 | P51826 | |
| CTCKKEPSSVSPSAT | 531 | P43681 | |
| ALGPDATSSCTKTPS | 826 | Q5SNV9 | |
| CAPISSSKSNGLSKD | 191 | Q8TF27 | |
| CFSPGISSTTSPKLN | 421 | Q5VTM2 | |
| YSEPKSTPKGACATS | 26 | P51857 | |
| PSDNVSSSTKKPAPC | 341 | P30556 | |
| TSNPFKSSKCSTAGS | 346 | Q5M775 | |
| KSSKCSTAGSSPNSV | 351 | Q5M775 | |
| PHSQPSFCSSAKSGK | 416 | Q9UI46 | |
| SPSCSNGVASTKSKQ | 386 | Q6VN20 | |
| SPSKSPAKLNQSGTS | 2276 | P49792 | |
| SGYPPSTTKIKSCST | 271 | Q2KHR3 | |
| TSFCPDTPSEKTAKG | 51 | A9QM74 | |
| DDKSCPSTPSSGATV | 1756 | Q7RTP6 | |
| CSPSSQPSLGSSTKF | 91 | Q9NTI7 | |
| NCTSGSSKPNSPSIS | 851 | Q99700 | |
| SGQDSSSSSVCIPPK | 461 | Q8NDZ0 | |
| KLCSSAAGSSAPKPA | 6 | A6NLJ0 | |
| TSTGPACTQPAKTTA | 646 | A6NKB5 | |
| SFQSSPCNKSPKSHG | 86 | Q12986 | |
| SPGSSSPQLQVKSSC | 616 | Q8N3F8 | |
| SSPQASSPTKKPCSL | 266 | Q96FV0 | |
| STPSSSPSSQKSCLQ | 156 | C9JSJ3 | |
| SSACTSPAVGKAKSS | 321 | Q9NYZ3 | |
| SKSCSQGSSTPRKQP | 1406 | P29375 | |
| VKATGNSTPCTSSLP | 336 | Q13952 | |
| SPTALSGSKTNSPKN | 391 | Q8N264 | |
| CSKNTSPTTQPTASG | 526 | Q92908 | |
| HSVPSQPKSSQTKSC | 961 | Q9BX69 | |
| QSQPSQTKPSPCKST | 976 | Q9BX69 | |
| GKKCAPESEPSNSTE | 1476 | Q13936 | |
| DQSKPNCTKDSTSGS | 71 | Q8TBM8 | |
| PPESSGCKTLTSSQA | 581 | P09958 | |
| GSNPTSGKPTITCSS | 151 | P17213 | |
| KRSNSKGCLTTPNSP | 256 | O75128 | |
| PESGSKDPSKNDTCK | 106 | O43169 | |
| KSTLSAPTSPCSQSA | 371 | Q2V2M9 | |
| SSTSPSKHSLPKSCT | 1986 | Q5VT06 | |
| NGCVPSPSDAKSISS | 1346 | Q9P267 | |
| CSSALASKPSPEGAS | 406 | P19235 | |
| SSTPNSFGASKPCTE | 506 | P54198 | |
| DPPSAKKSIPSSECS | 226 | Q92681 | |
| PSSCGSLPITNSFTK | 536 | Q9BXL7 | |
| TCENSPKSPKVTGTA | 2601 | Q02224 | |
| SDSEKCSPTVSQGKS | 106 | O43781 | |
| ISGPECTTPKASTSA | 426 | Q5VWG9 | |
| SCPKTKTDGSPKSTS | 2961 | Q5T011 | |
| SPSKSPAKLNQSGTS | 1301 | Q7Z3J3 | |
| STTKSASCQPREKSG | 646 | A6NI28 | |
| KVTPCSECKSSSSPG | 51 | P0DPB3 | |
| SSNQKSPTKTSKSPG | 2221 | P25391 | |
| KDKACSPTSGSPTAG | 506 | O75626 | |
| TKVTPCSECKSSSSP | 126 | B3KU38 | |
| KPKASPSCSSPTRDS | 6 | Q8N5I9 | |
| SISGSKKPTNDSNPS | 411 | Q68D10 | |
| SKALGAKGSCETTPS | 71 | Q96K30 | |
| KSSSQPSSCCSDPSK | 281 | Q13501 | |
| TCGQDPPKSASSTKS | 891 | P51825 | |
| SSEPNTPKSAKCEGD | 1421 | Q96RK0 | |
| TGKAVSEPSCTTNTK | 211 | Q8IXR9 | |
| CTQPKSPSGTVCTSK | 66 | O15393 | |
| NSQISCTGSSKKPPN | 831 | A4D1E1 | |
| PKTQACSGSESPSDS | 151 | P12524 | |
| GQKPTPCLSSTSKAQ | 56 | P0C7P2 | |
| PGSDSTTCSSAKSKG | 1136 | Q9P227 | |
| CATSKESPPTGDSGK | 186 | Q6ZMT1 | |
| SSSSSDPKIKQPNGS | 1626 | Q92545 | |
| CGSKKPDPTVASGSS | 851 | Q9Y6L7 | |
| ADSACSSPAPSTGKV | 356 | Q9GZR1 | |
| GLSSSPPKKCARSES | 266 | O94888 | |
| ASTPASKSCDSSPPQ | 296 | Q04725 | |
| AGQPSKKPSTLLSCS | 481 | Q6BDS2 | |
| CKQDNSSSPKPSSVF | 481 | Q7Z4V0 | |
| PKGSPSSSRKSGTSC | 1171 | P35125 | |
| RKSGTSCPSSKNSSP | 1381 | Q8NFA0 | |
| SPPTNKIGSKSSNAS | 1461 | Q9UPQ9 | |
| PCPSSSAKGTAVNFS | 41 | P07947 | |
| SKGTKDSPSVCSNLA | 566 | Q9UGR2 | |
| SSSCSSSPGVKSPDA | 686 | Q01538 |